Noah Goodman

Noah Goodman is an experienced executive in the biotechnology and pharmaceutical sectors, currently serving as Chief Business Officer at Kymera Therapeutics since April 2025. Prior to this role, Goodman held the position of President and Chief Business Officer at nChroma Bio and Chroma Medicine, where leadership extended to overseeing business operations from May 2021 to April 2025. Goodman's earlier experience includes serving as Executive Director of Business Development at Cadent Therapeutics, which was acquired by Novartis, and as Director of Business Development and Strategy at Seres Therapeutics. Goodman's professional journey began at Easton Associates, providing business development consulting across various healthcare sectors. Noah Goodman holds an MBA in Health Care Management from The Wharton School and a B.S. with Honors in Neuroscience from the University of Michigan.